• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Amwell Appoints Roy Schoenberg to Executive Vice Chairman, Ido Schoenberg to Serve as Sole CEO

by Executive Hires 06/14/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Roy Schoenberg, M.D., M.P.H, Executive Vice Chairman of the Board

What You Should Know: 

– Amwell announced a significant leadership transition. Co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., will transition from his role as president and co-CEO to become the Executive Vice Chairman of Amwell’s Board of Directors. 

– Ido Schoenberg, M.D., will take on the role of sole Chief Executive Officer of Amwell.

Roy Schoenberg Background

Since co-founding Amwell in 2006, Roy Schoenberg has been a pivotal force in the advancement of digital healthcare. His vision to democratize healthcare access and distribution through modern technology has fundamentally reshaped the patient and clinician experience in digital care. Under his leadership, Amwell has introduced new efficiencies, embraced care automation, healthcare AI, and related technologies, elevating the standards and reach of patient care.

During the COVID-19 pandemic, Roy Schoenberg’s efforts were instrumental in ensuring that the healthcare industry could fulfill its obligations to patients through technology. He worked closely with payers, providers, and regulators to maintain continuity of care, even as in-person services were disrupted. His leadership helped expand the Amwell platform, which now connects over 100,000 active clinicians with millions of patients worldwide.

As the world emerged from the pandemic, Roy Schoenberg began developing the Amwell Converge™ platform. This next-generation platform is designed to meet the evolving expectations of a healthcare landscape that balances in-person and digital experiences. Roy’s mission to bring healthcare directly to patients remains at the core of Amwell’s objectives.

Ido Schoenberg, who will now serve as the sole CEO, has been an integral part of Amwell’s leadership alongside Roy. Together, they have guided the company through significant growth and innovation. Ido’s continued leadership is expected to drive Amwell forward in its mission to provide accessible, high-quality digital care.

“The time is now to take the next step in our mission. Our unique opportunity to realize the immense value in new Amwell technology – while achieving critical operational and clinical goals – is both timely and exciting. I am confident in our talented leadership team and will continue to support them in our journey to digitally reimagine healthcare,” said Roy Schoenberg, newly appointed Amwell Executive Vice Chairman.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |